1. Bcl-2 antisense therapy in B-cell malignant proliferative disorders

   • Asher Chanan-Khan
   • Myron S. Czuczman

   OriginalPaper Pages: 261 - 267

2. The emerging role of bortezomib in the treatment of indolent non-hodgkin’ and mantle cell lymphomas

   • Owen A. O’Connor

   OriginalPaper Pages: 269 - 281

3. Epratuzumab in non-hodgkin’ lymphomas

   • Richard R. Furman
   • Morton Coleman
   • John P. Leonard

   OriginalPaper Pages: 283 - 288

4. Treatment of T-cell non-hodgkin’ lymphoma

   • Andrew M. Evens
   • Ronald B. Gartenhaus

   OriginalPaper Pages: 289 - 303

5. Primary thyroid lymphomas

   • Sandy Widder
   • Janice L. Pasieka

   OriginalPaper Pages: 307 - 313

6. Multiple endocrine neoplasia type 2

   • Michael E. Gertner
   • Electron Kebebew

   OriginalPaper Pages: 315 - 325

7. Unusual functioning endocrine tumors

   • Chandrajit P. Raut
   • Jeffrey E. Lee

   OriginalPaper Pages: 327 - 334

8. Persistent and recurrent hyperparathyroidism

   • Nadine R. Caron
   • Cord Sturgeon
   • Orlo H. Clark

   OriginalPaper Pages: 335 - 345